Solasto Corporation

6197.T
Medical Care Facilities
2026/03/27 Updated
Market Cap: $635.0M (¥101.1B)
Stock Price: $7.00 (¥1,115)
Exchange Rate: 1 USD = ¥159.24

Notice Regarding the Commencement of Tender Offer by MP-2605 Co., Ltd. for Common Shares of Solasto Corporation (Securities Code: 6197) as Part of MBO

MP-2605 Co., Ltd. has commenced a tender offer to acquire 58,886,124 common shares of Solasto Corporation at 1,119 yen per share. The offer period is from March 25, 2026 to May 11, 2026.

Importance:
Page Updated: March 24, 2026
IR Disclosure Date: March 24, 2026

Key Figures

  • Number of shares planned to be purchased: 58,886,124 shares
  • Purchase price: 1,119 yen per share
  • Purchase period: March 25, 2026 to May 11, 2026 (30 business days)

AI要約

Overview of Tender Offer

MP-2605 Co., Ltd., established on February 10, 2026, has commenced a tender offer to acquire 58,886,124 common shares of Solasto Corporation at 1,119 yen per share. The offer period is 30 business days from March 25, 2026 to May 11, 2026, with the settlement start date on May 18, 2026. This tender offer is part of a management buyout (MBO) aiming to take the target shares private. The lower limit for the number of shares to be purchased is set at 28,530,600 shares, and if this threshold is not met, the purchase will not proceed.

Background of MBO and Future Procedures

This transaction is an MBO led by President and CEO Toru Noda of MP-2605 Co., Ltd., with involvement from MBK Partners. Agreements have been reached with the employee shareholding association of the eligible persons and Daito Trust Construction Co., Ltd. concerning continued holdings and non-subscription of shares. A series of capital measures including share consolidation, share buyback, and squeeze-out procedures are planned. Mr. Noda will continue to be involved in management post-MBO and aims to enhance corporate value of the target entity.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.